talk-icon

NM06.06.01 : Clinical Validation of Nanodiamonds—Opportunities to Harness Augmented AI to Optimize Nanomedicine

10:00 AM–10:30 AM Apr 4, 2018 (America - Denver)

PCC North, 200 Level, Room 227 BC

Description
Dean Ho1

1, University of California, Los Angeles, Los Angeles, California, United States

This lecture will highlight our recent clinical trial to validate a nanodiamond-embedded biomaterial [1]. We will discuss the broad spectrum of efficacy, safety, characterization, and other studies that bridged in vitro with preclinical and downstream in-human studies. To provide an outlook for upcoming clinical studies, this talk will also highlight our work in augmented AI to develop globally optimized nanodiamond-modified therapy. Pairing nanodiamond platforms with augmented AI will lead to major advances in drug development and markedly improve response rates for a broad spectrum of disorders. This talk will also highlight our recent clinical trials using these powerful combination therapy optimization technologies and how they will usher in a new era of nanomedicine-based treatment [2].

1. Lee et al., Proceedings of the National Academy of Sciences, 2017
2. Zarrinpar et al., Science Translational Medicine, 2016

Tags